• DOI:10.1007/s11910-018-0814-x
Corpus ID: 3375801

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews

@article{Nielsen2018TheUO,
  title={The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews},
  author={S. Nielsen and Rada Germanos and M. Weier and J. Pollard and L. Degenhardt and W. Hall and N. Buckley and M. Farrell},
  journal={Current Neurology and Neuroscience Reports},
  year={2018},
  volume={18},
  pages={1-12}
}

S. Nielsen, Rada Germanos, +5 authors M. Farrell

Published 2018

Medicine

Current Neurology and Neuroscience Reports

Purpose of ReviewPharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plant-based cannabinoids have been investigated for their therapeutic potential in treating multiple sclerosis (MS) symptoms. This review of reviews aimed to synthesise findings from high quality systematic reviews that examined the safety and effectiveness of cannabinoids in multiple sclerosis. We examined the outcomes of disability and disability progression, pain, spasticity, bladder function… CONTINUE READING

View on Springer

ses.library.usyd.edu.au

Save to Library

Create Alert

Cite

Launch Research Feed